BCD-225

N/A

Report date: 2022/02/16 16:14:28

Base Information

Drug NameBCD-225

Drug Alias NameBCD-225

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein

Mechanisms of ActionInterleukin-15 receptor subunit alpha agonists

TargetsInterleukin-15 receptor subunit alpha

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBIOCAD JSC

China Registration ClassN/A

Active CompaniesBIOCAD JSC

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A